Avantium signs license agreement to use Eastman’s FDCA-related patent portfolio


Type of post: NEWS IN BRIEF.

Avantium has announced that its subsidiary Avantium Renewable Polymers has signed a patent license agreement with Eastman Chemical Company for the right to operate under Eastman’s FDCA-related patent portfolio.
Related posts: FDCA.

This patent license agreement further paves the way for the commercial production of FDCA (furandicarboxylic acid) and PEF (polyethylene furanoate) from Avantium FDCA flagship plant, which dependent on a positive final investment decision, is planned to start up in 2023.

The licence will also be available for any subsequent industrial scale facility built on the basis of Avantium’s FDCA and PEF technology. Under the agreement, Avantium will pay Eastman a licensing fee and ongoing royalty payments related to manufactured volumes. Payments will be partly made in Avantium shares.

Popular Posts

Biorrefinerías de ácido levulínico

Hydrotreating (HVO) – Advantages over FAME and properties

New HVO plant enters into operation in China

Biorrefinerías de ácido succínico

Braskem and Sojitz launch Sustainea to produce and market biobased glycols